EndoChoice® Selected as One of The Best and Brightest to Work For™

ATLANTA, May 14, 2014 /PRNewswire/ -- EndoChoice^® has been named as one of "Atlanta's Best and Brightest Companies to Work For™", a designation that hundreds of companies pursue. EndoChoice was identified as a company that delivers exceptional human resource practices as measured by the National Association for Business Resources.

An independent research firm evaluates each company's entry based on key measures in various categories. They include Compensation, Benefits and Employee Solutions; Employee Enrichment, Engagement and Retention; Employee Education and Development; Recruitment, Selection and Orientation; Employee Achievement and Recognition; Communication and Shared Vision; Diversity and Inclusion; Work-Life Balance; Community Initiatives; Strategic Company Performance; and, the Best of the Best Small Business.

"The selection, recognition and awarding of this year's Best and Brightest companies allows our organization to showcase their best practices. The honorees have clearly demonstrated why each of them would be an ideal place for employees to work. The companies that we are recognizing this year are an example of exceptional human resource practices and represent high standards in today's economic climate," said Jennifer Kluge, NABR president.

EndoChoice has earned this award while more than doubling in size since January 2013.  As the fastest growing medtech company in the US, EndoChoice has expanded its facilities in Atlanta while also growing staff numbers within its EndoChoice Innovation Center in Caesarea, Israel and International Headquarters in Hamburg, Germany.

"The common thread that runs through all our associates is something we call CHIE," said Kristen Schuller, EndoChoice's Vice-President of Human Resources. "CHIE stands for clever, high quality, innovative and exceeding expectations.  No matter where we hire new talent we find people that want to embrace CHIE, and that makes our team truly unique."

EndoChoice founder and CEO, Mark Gilreath added, "It's a true privilege to work with such a highly engaged team, sharing a common vision.  This is our secret to high performance."

About EndoChoice

Based in Atlanta GA, EndoChoice^® is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal (GI) diseases.  EndoChoice leverages its direct sales organization to serve more than 2,000 customers in the United States and works with 34 distribution partners world-wide.  The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy™ System (Fuse®).  The Fuse System is comprised of colonoscopes and gastroscopes with multiple imagers so doctors can see more of the GI tract for diagnosis and treatment.  The Fuse colonoscope provides a field of view of 330 degrees versus 170 degrees from traditional endoscopes.  In a recent clinical study Fuse found 69% more pre-cancerous polyps than traditional colonoscopes.  2013 marked the fourth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine.  To learn more, visit www.endochoice.com

EndoChoice and Fuse^® are registered trademarks of EndoChoice, Inc.

For more information, press only:
Doug Ladd, Chief Marketing Officer
513-608-6873 or [email protected]

SOURCE EndoChoice